[DoctorsforObama] RE: McCain' Medical Records: Recurring Melanoma,
Hyperlipidemia, and Degenerative Joint Disease
>"David E. Kolva, MD " wrote: > wrote:
This is a remarkably accurate letter. The American public must have answers to the question of McCain's health. We have NEVER BEFORE elected anyone to this office at this age.
David Kolva, MD
SUNY Upstate Medical University
From: Michael Fratkin [mailto:email@example.com]
To: Doctors for Obama
Subject: [DoctorsforObama] McCain' Medical Records
Dear Colleagues and Friends,
These are the limited facts the American people have had access to. Over 1000 pages of medical records were shown to selected journalists for 3 hours with less than 48 hours of notice. The only medically trained journalist was Sanjay Gupta, MD.
[Sanjay Gupta is an American physicians of Indian descent and a Contributing CNN Chief Health correspondent. ]
This is the extent to which the American people have been informed. While I am certainly sensitive to the confidential nature of medical records, given the anxiety expressed by many of my patients regarding the risk of lost coverage or lost jobs in this current health economic climate, there are certain exceptions for disclosure regarding public safety.
As John McCain knows, a pilot's records are comprehensively available for review by a certifying agency (the FAA) to insure the fitness of the pilot and the safety of passengers and the public at-large. In the election of the President of the United States of America, that certifying body is the American electorate.
A recurrence of metastatic malignant melanoma would essentially destroy John McCain's capacity as the Chief Executive, and the American People have yet to receive a full accounting of the facts regarding his actuarial risk.
distant metastasis to the brain, bone, and lung.
As you all know, melanoma is one of the most insidious, pernicious, and
aggressive malignancies our patients must deal with and that we attempt somewhat pathetically to control with interferon, interleukins, and dismally active and terribly toxic chemotherapeutic regimens.
In addition, we lack the simple data to sensibly evaluate his cardiovascular risk as we would any septuagenerian in our exam rooms.